Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

64 structures for Q93009

Entry ID Method Resolution Chain Position Source
1NB8 X-ray 230 A A/B 208-560 PDB
1NBF X-ray 230 A A/B/E 208-560 PDB
1YY6 X-ray 170 A A 54-204 PDB
1YZE X-ray 200 A A/B/C 54-205 PDB
2F1W X-ray 165 A A 53-206 PDB
2F1X X-ray 230 A A/B 53-200 PDB
2F1Y X-ray 170 A A 53-198 PDB
2F1Z X-ray 320 A A/B 43-560 PDB
2FOJ X-ray 160 A A 54-205 PDB
2FOO X-ray 220 A A 54-205 PDB
2FOP X-ray 210 A A 54-205 PDB
2KVR NMR - A 537-664 PDB
2XXN X-ray 160 A A 63-205 PDB
2YLM X-ray 270 A A 560-1084 PDB
3MQR X-ray 180 A A 54-205 PDB
3MQS X-ray 240 A C 54-205 PDB
4JJQ X-ray 195 A A 54-205 PDB
4KG9 X-ray 170 A A 54-205 PDB
4M5W X-ray 224 A A 207-560 PDB
4M5X X-ray 219 A A/B 207-560 PDB
4PYZ X-ray 284 A A/B 537-793 PDB
4WPH X-ray 292 A A/B 535-888 PDB
4WPI X-ray 340 A A/B 535-888 PDB
4YOC X-ray 292 A C 560-1102 PDB
4YSI X-ray 102 A A 63-205 PDB
4Z96 X-ray 285 A A 560-1083 PDB
4Z97 X-ray 300 A A 560-1083 PDB
5C56 X-ray 269 A A 560-1102 PDB
5C6D X-ray 229 A A/B 561-881 PDB
5FWI X-ray 340 A C 207-882 PDB
5GG4 X-ray 311 A A/B/C/D 560-890 PDB
5J7T X-ray 320 A A 211-881 PDB
5JTJ X-ray 332 A PDB
5JTV X-ray 331 A PDB
5KYB X-ray 220 A A/B 208-554 PDB
5KYC X-ray 143 A B 208-554 PDB
5KYD X-ray 162 A A 208-554 PDB
5KYE X-ray 197 A A/B 208-554 PDB
5KYF X-ray 145 A B 208-554 PDB
5N9R X-ray 223 A A/B 207-560 PDB
5N9T X-ray 173 A A/B 207-560 PDB
5NGE X-ray 235 A A/B 208-560 PDB
5NGF X-ray 233 A A/B 208-560 PDB
5UQV X-ray 284 A A/B 208-554 PDB
5UQX X-ray 223 A A/B 208-555 PDB
5VS6 X-ray 227 A A/B 208-560 PDB
5VSB X-ray 185 A A/B 208-560 PDB
5VSK X-ray 333 A A/B 208-560 PDB
5WHC X-ray 255 A A/B 209-554 PDB
6F5H X-ray 216 A A/B 207-560 PDB
6M1K X-ray 225 A A/B 208-554 PDB
6P5L X-ray 330 A A/B 535-890 PDB
6VN2 X-ray 293 A A/B 207-555 PDB
6VN3 X-ray 273 A A/B 207-555 PDB
6VN4 X-ray 269 A A/B 207-555 PDB
6VN5 X-ray 290 A A/B 207-555 PDB
6VN6 X-ray 299 A A/B 207-555 PDB
7CM2 X-ray 225 A A/B 208-560 PDB
7VIJ X-ray 230 A A 560-1083 PDB
7XHH X-ray 210 A A/B 207-554 PDB
7XHK X-ray 230 A B 211-553 PDB
7XPY X-ray 235 A A 560-1102 PDB
8D4Z X-ray 226 A A/B 207-560 PDB
AF-Q93009-F1 Predicted AlphaFoldDB

477 variants for Q93009

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1898245285
RCV001249770
53 N>S USP7-related neurodevelopmental disorder [ClinVar] Yes ClinVar
dbSNP
rs769761004
RCV000735279
CA394705373
111 H>Q Macrocephaly [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000210289
rs756550597
CA354994
143 Y>* Hao-Fountain syndrome [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
VAR_086825 143 Y>del HAFOUS; when expressed in USP7-deficient cells does not rescue defective endosomal protein recycling and reduced F-actin levels [UniProt] Yes UniProt
RCV001175170
CA394704280
rs1555465642
VAR_086826
RCV000509482
225 M>I Hao-Fountain syndrome HAFOUS [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
VAR_086827 345 E>K HAFOUS [UniProt] Yes UniProt
rs2062011160
RCV001266692
348 Y>H Inborn genetic diseases [ClinVar] Yes ClinVar
dbSNP
VAR_086828 373 L>F HAFOUS [UniProt] Yes UniProt
VAR_086829 392 G>D HAFOUS [UniProt] Yes UniProt
VAR_086830 485 V>G HAFOUS [UniProt] Yes UniProt
RCV001175168
rs2061808524
576 C>* Hao-Fountain syndrome [ClinVar] Yes ClinVar
dbSNP
VAR_086831 576 C>del HAFOUS [UniProt] Yes UniProt
RCV000625999
RCV001175169
rs1555462347
723 R>missing Hao-Fountain syndrome [ClinVar] Yes ClinVar
dbSNP
VAR_086832 757 L>P HAFOUS; unknown pathological significance; the patient also carries a de novo clinically relevant variant in SLC2A1 [UniProt] Yes UniProt
VAR_086833 766 I>T HAFOUS [UniProt] Yes UniProt
RCV001095726
rs2061656880
RCV002462328
1031 Q>E USP7-related neurodevelopmental disorder [ClinVar] Yes ClinVar
dbSNP
VAR_086834 1080 D>N HAFOUS [UniProt] Yes UniProt
CA394693379
COSM1232123
rs1213557591
3 H>Q large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA394693385
rs1272991796
3 H>R No ClinGen
TOPMed
CA277506301
rs901790687
3 H>Y No ClinGen
TOPMed
gnomAD
COSM1380634
CA7895909
rs750093857
4 Q>H large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
CA394693349
rs1333347169
COSM3691282
5 Q>H large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
rs1223248807
CA394693330
6 Q>L No ClinGen
TOPMed
gnomAD
CA394693319
rs1224706884
7 Q>E No ClinGen
gnomAD
CA394693251
rs1435667134
11 K>Q No ClinGen
TOPMed
CA394693225
rs1372127093
12 A>V No ClinGen
TOPMed
gnomAD
rs1277447483
CA394693219
13 G>D No ClinGen
TOPMed
gnomAD
rs1324650917
CA394693138
18 S>R No ClinGen
gnomAD
rs1394655023
CA394693141
18 S>T No ClinGen
TOPMed
gnomAD
rs887172330
CA277506283
19 E>D No ClinGen
TOPMed
gnomAD
rs1005133765
CA277506288
19 E>G No ClinGen
TOPMed
gnomAD
rs1293614426
CA394693134
19 E>Q No ClinGen
gnomAD
rs1047199606
CA277506276
20 P>L No ClinGen
TOPMed
gnomAD
CA277506265
rs919912952
21 E>V No ClinGen
TOPMed
CA277506259
rs867428437
22 D>N No ClinGen
gnomAD
CA394693086
rs1175764488
22 D>V No ClinGen
gnomAD
CA394693092
rs867428437
22 D>Y No ClinGen
gnomAD
rs1248152824
CA394693074
23 M>T No ClinGen
TOPMed
CA394693083
rs1455760136
23 M>V No ClinGen
gnomAD
rs1045125836
CA277506252
24 E>V No ClinGen
TOPMed
gnomAD
rs1186067195
CA394693035
25 M>I No ClinGen
TOPMed
CA394693050
rs1304314616
25 M>V No ClinGen
gnomAD
CA394693026
rs1389183291
26 E>G No ClinGen
TOPMed
CA394707825
rs370070575
27 A>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs370070575
CA7895836
COSM1380633
27 A>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA277547889
rs1020054806
29 D>V No ClinGen
TOPMed
rs1197228070
CA394707801
31 D>A No ClinGen
gnomAD
rs759508713
CA7895834
33 P>S No ClinGen
ExAC
gnomAD
CA277547873
rs992972868
34 P>Q No ClinGen
Ensembl
CA394707781
rs1219502323
34 P>S No ClinGen
TOPMed
CA394707778
rs1488207861
35 R>G No ClinGen
TOPMed
CA394707775
rs1280999076
35 R>T No ClinGen
gnomAD
CA7895832
rs771556702
36 I>V No ClinGen
ExAC
gnomAD
CA7895831
rs146962536
37 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7895829
rs769574241
38 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs773653401
CA7895830
38 Q>K No ClinGen
ExAC
TOPMed
gnomAD
CA7895828
rs747795179
CA394707748
39 N>K No ClinGen
ExAC
gnomAD
CA394707750
rs1421415184
39 N>S No ClinGen
TOPMed
CA394707746
rs1319317174
40 P>A No ClinGen
gnomAD
rs1156816715
CA394707743
40 P>R No ClinGen
TOPMed
rs201497079
CA277547780
43 N>S No ClinGen
1000Genomes
TOPMed
rs768254284
CA7895826
46 V>L No ClinGen
ExAC
gnomAD
CA277547743
rs1034639985
53 N>H No ClinGen
Ensembl
rs750227103
CA394707579
55 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA7895822
rs750227103
55 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs560277695
CA7895821
55 A>V Variant assessed as Somatic; 9.245e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1221294205
CA394707564
56 E>D No ClinGen
gnomAD
rs768421982
CA277547707
58 D>Y No ClinGen
Ensembl
rs1223925831
CA394707526
59 M>T No ClinGen
TOPMed
gnomAD
CA394707514
rs1372192859
60 E>K No ClinGen
gnomAD
rs1245073527
CA394706352
62 D>G No ClinGen
TOPMed
rs753015445
CA7895817
62 D>N No ClinGen
ExAC
CA7895779
rs564927709
63 T>S No ClinGen
1000Genomes
ExAC
gnomAD
CA7895778
rs777361076
64 S>C No ClinGen
ExAC
gnomAD
rs747177984
CA7895776
66 R>L No ClinGen
ExAC
gnomAD
CA394706276
rs1302502113
70 T>A No ClinGen
TOPMed
gnomAD
rs758589839
CA7895774
77 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA394705764
rs1341264405
79 S>C No ClinGen
TOPMed
gnomAD
CA394705767
rs1341264405
79 S>G No ClinGen
TOPMed
gnomAD
CA394705749
rs1410705244
80 R>K No ClinGen
TOPMed
CA7895770
rs754262044
87 S>G No ClinGen
ExAC
gnomAD
rs761007449
CA7895768
88 P>T No ClinGen
ExAC
gnomAD
CA7895767
rs775166718
89 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA394705467
rs1184882631
103 P>L No ClinGen
gnomAD
CA277538980
rs200389222
107 P>A No ClinGen
Ensembl
CA394705357
rs144116379
112 Q>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA394705361
rs1375455229
112 Q>L No ClinGen
TOPMed
TCGA novel 114 S>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 114 S>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895758
rs780483368
115 V>I No ClinGen
ExAC
gnomAD
rs1350062498
CA394705271
119 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 128 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394704976
rs1347393272
131 S>C No ClinGen
gnomAD
CA394704957
rs1567225519
134 A>T No ClinGen
Ensembl
rs770958985
CA394704932
138 L>M No ClinGen
ExAC
TOPMed
gnomAD
CA7895723
rs749385823
140 I>V No ClinGen
ExAC
gnomAD
rs1262216962
CA620764648
141 I>* No ClinGen
gnomAD
CA277536405
rs961744979
145 D>N No ClinGen
TOPMed
gnomAD
TCGA novel 146 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA277536387
rs1014628338
147 E>D No ClinGen
TOPMed
rs1282497980
CA394704856
148 K>N No ClinGen
gnomAD
rs1273656761
CA394704836
151 S>N No ClinGen
gnomAD
CA394704823
rs1567225460
153 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA7895718
rs754646361
160 H>P No ClinGen
ExAC
gnomAD
rs766023368
CA7895716
169 N>S No ClinGen
ExAC
gnomAD
TCGA novel 170 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394704689
rs1334224039
171 M>L No ClinGen
gnomAD
TCGA novel 171 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749891129
CA7895714
174 S>N No ClinGen
ExAC
gnomAD
CA7895682
rs372645978
176 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7895681
rs769192378
177 T>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 178 D>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1156582850
CA394704630
178 D>N No ClinGen
TOPMed
rs373931498
CA277535079
179 P>L No ClinGen
ESP
TOPMed
gnomAD
TCGA novel 181 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895677
rs530191108
190 T>A No ClinGen
1000Genomes
ExAC
gnomAD
rs1419319278
CA394704537
190 T>S No ClinGen
TOPMed
rs778680603
CA7895676
191 F>C No ClinGen
ExAC
TOPMed
gnomAD
rs1435707242
CA394704514
194 F>L No ClinGen
Ensembl
TCGA novel 198 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 208 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895645
rs760642910
213 Y>C No ClinGen
ExAC
gnomAD
rs200156369
CA277533105
214 V>I No ClinGen
Ensembl
TCGA novel 215 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs774794168
CA7895642
217 K>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 223 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200265162
CA277533029
230 Q>R No ClinGen
1000Genomes
CA277532996
rs937161725
235 T>M No ClinGen
Ensembl
rs781247345
RCV000986176
CA394704188
239 R>* No ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs758258486
CA7895612
244 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs745639108
CA7895611
247 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA7895608
rs752857703
252 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 253 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 262 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394703937
rs1387771396
272 K>R No ClinGen
gnomAD
TCGA novel 279 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1300834863 279 L>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 282 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394703801
rs1183826361
290 S>G No ClinGen
gnomAD
CA394703729
rs1215472112
299 L>V No ClinGen
Ensembl
TCGA novel 301 R>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 305 D>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs371261156
CA7895546
313 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA277527759
rs201852256
317 E>G No ClinGen
1000Genomes
TCGA novel 323 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA277527741
rs765536244
325 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA277527751
rs765536244
325 R>G No ClinGen
TOPMed
gnomAD
CA7895541
rs747180128
327 K>R No ClinGen
ExAC
gnomAD
TCGA novel 332 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 332 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM1302378
CA394703448
rs1414477841
336 E>K Variant assessed as Somatic; impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA394703430
rs1343926478
338 D>G No ClinGen
gnomAD
CA277527605
COSM559615
rs944748771
340 R>W lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
TCGA novel 342 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394703322
rs1416680806
353 S>T No ClinGen
gnomAD
CA394703276
rs1229878827
359 N>S No ClinGen
Ensembl
CA7895478
rs749894577
361 F>L No ClinGen
ExAC
gnomAD
rs762632614
CA277516408
361 F>S No ClinGen
gnomAD
CA394703194
rs1352445138
369 A>S No ClinGen
gnomAD
rs1352445138
CA394703196
369 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA394703189
rs1383982134
370 V>I No ClinGen
TOPMed
CA394703169
rs1567217225
372 Q>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs375864487
CA277516383
374 D>H No ClinGen
ESP
TOPMed
rs375864487
CA394703162
374 D>N No ClinGen
ESP
TOPMed
TCGA novel 375 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 380 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895473
CA394703091
rs760352754
383 E>D No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 383 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895456
rs777564543
390 E>D No ClinGen
ExAC
gnomAD
TCGA novel 391 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs755998936
CA7895455
396 L>V No ClinGen
ExAC
gnomAD
CA7895453
rs766595112
398 L>F No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 420 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 423 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1174494552
CA394702197
428 P>S No ClinGen
gnomAD
rs1596361901
CA394702187
429 E>D No ClinGen
Ensembl
rs774200982
CA7895422
430 Q>R No ClinGen
ExAC
gnomAD
CA394702112
rs1479244690
440 T>A No ClinGen
TOPMed
TCGA novel 440 T>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 440 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1039637527
CA277512455
441 D>E No ClinGen
TOPMed
gnomAD
CA7895421
rs770435953
442 P>S No ClinGen
ExAC
CA277512441
rs868290938
445 P>L No ClinGen
Ensembl
rs748840212
CA7895420
449 I>T No ClinGen
ExAC
gnomAD
TCGA novel 450 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394702007
rs1347944769
456 H>D No ClinGen
Ensembl
CA7895416
rs781077969
456 H>L No ClinGen
ExAC
gnomAD
rs1386022252
CA394701893
472 K>R No ClinGen
TOPMed
rs753971593
CA7895411
474 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA7895408
rs753320462
476 K>N No ClinGen
ExAC
gnomAD
CA7895409
rs147329800
476 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs147329800
CA7895410
476 K>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1424551372
CA394701840
478 C>Y No ClinGen
gnomAD
TCGA novel 483 D>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 484 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 488 C>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394701723
rs1328043751
494 I>V No ClinGen
gnomAD
rs1357175448
CA394701698
497 N>S No ClinGen
gnomAD
CA394701673
rs1245204196
501 H>D No ClinGen
TOPMed
CA277510996
rs375970067
501 H>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7895382
rs761326339
502 D>N No ClinGen
ExAC
gnomAD
TCGA novel 504 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs2061841667
RCV001091965
508 R>* No ClinVar
dbSNP
TCGA novel 509 H>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394701618
rs1161832673
509 H>R No ClinGen
gnomAD
rs775465927
CA7895377
511 T>A No ClinGen
ExAC
gnomAD
CA7895376
rs771825799
511 T>I No ClinGen
ExAC
gnomAD
rs1312508442
CA394701598
512 N>S No ClinGen
gnomAD
CA7895372
rs748273634
520 R>K No ClinGen
ExAC
gnomAD
CA394701527
rs1414901969
522 S>A No ClinGen
TOPMed
rs763719614
CA277509676
530 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA394701456
rs763719614
530 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs763719614
COSM180165
CA7895339
530 A>V Variant assessed as Somatic; 0.0 impact. large_intestine central_nervous_system [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA7895337
rs752181569
531 V>F No ClinGen
ExAC
gnomAD
rs1596359274
CA394701451
531 V>G No ClinGen
Ensembl
TCGA novel 532 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767383534
CA7895336
532 T>I No ClinGen
ExAC
gnomAD
rs374207468
CA7895335
COSM180164
533 D>N large_intestine Variant assessed as Somatic; 4.636e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA277509646
rs1054620951
534 H>R No ClinGen
TOPMed
rs766321600
CA7895333
535 D>N No ClinGen
ExAC
gnomAD
rs1445192569
CA394701422
536 I>V No ClinGen
gnomAD
TCGA novel 538 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895331
rs777052576
538 Q>H No ClinGen
ExAC
gnomAD
rs768865469
CA7895330
540 L>M No ClinGen
ExAC
gnomAD
TCGA novel 541 V>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1567212542
CA394701378
542 E>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA277509634
rs775600919
543 R>L No ClinGen
ExAC
gnomAD
rs775600919
CA7895328
543 R>Q No ClinGen
ExAC
gnomAD
TCGA novel 545 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394701351
rs1205492244
546 E>D No ClinGen
gnomAD
CA394701353
rs1216655785
546 E>V No ClinGen
gnomAD
CA7895327
rs746412580
550 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA394701290
rs1567212497
555 R>W No ClinGen
Ensembl
rs1314790441
CA394701286
556 K>Q No ClinGen
gnomAD
rs1008492376
CA277509605
558 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA7895324
rs757672263
558 R>W No ClinGen
ExAC
gnomAD
rs1596359159
CA394701255
560 E>G No ClinGen
Ensembl
CA394701236
rs1298331231
563 L>F No ClinGen
gnomAD
CA394701227
rs1244772203
564 Y>C No ClinGen
gnomAD
CA277508422
rs899546223
569 I>V No ClinGen
Ensembl
CA277508396
rs1038557108
570 V>L No ClinGen
Ensembl
CA7895287
rs767573729
571 A>S No ClinGen
ExAC
TOPMed
gnomAD
COSM1232121
CA7895288
rs767573729
571 A>T large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs150096079
CA7895284
579 Q>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA394701061
rs1480900512
585 D>G No ClinGen
gnomAD
TCGA novel 585 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1178806928
CA394701065
585 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 586 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394701041
rs1251891055
588 K>E No ClinGen
TOPMed
CA7895281
rs770264553
591 Y>C No ClinGen
ExAC
gnomAD
rs1262966173
CA394701011
592 T>A No ClinGen
TOPMed
gnomAD
rs1449987707
CA394701007
592 T>I No ClinGen
gnomAD
CA394701008
rs1449987707
592 T>S No ClinGen
gnomAD
rs1262966173
CA394701010
592 T>S No ClinGen
TOPMed
gnomAD
CA7895280
rs201855673
595 K>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1203882600
CA394700973
597 L>F No ClinGen
gnomAD
CA394700960
rs1322444938
599 N>S No ClinGen
gnomAD
rs768357840
COSM165457
CA7895278
601 S>L breast [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs199609011
CA277508295
603 A>P No ClinGen
1000Genomes
gnomAD
rs199609011
CA277508294
603 A>S No ClinGen
1000Genomes
gnomAD
rs540860113
CA7895276
603 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs757948670
CA7895275
604 E>K No ClinGen
ExAC
gnomAD
rs778702214
CA7895273
606 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs750439046
CA7895274
606 V>I No ClinGen
ExAC
rs1306720049
CA394700913
607 Q>R No ClinGen
TOPMed
gnomAD
CA7895272
rs757088246
608 S>N No ClinGen
ExAC
gnomAD
rs1171047002
CA394700886
611 Q>L No ClinGen
gnomAD
rs753507187
CA7895271
613 M>V No ClinGen
ExAC
gnomAD
CA277507162
rs970860239
618 D>N No ClinGen
Ensembl
TCGA novel 619 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1023761997
CA277507155
619 Q>E No ClinGen
Ensembl
CA277507143
rs1012336169
621 R>Q No ClinGen
Ensembl
rs1399019111
CA394700235
627 A>G No ClinGen
TOPMed
rs1179569842
CA394700121
636 A>T No ClinGen
gnomAD
CA394700109
rs1490684867
637 M>V No ClinGen
gnomAD
rs1321271900
CA394700080
639 D>N No ClinGen
gnomAD
CA7895220
rs560507838
640 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA394700062
rs1220708929
641 E>A No ClinGen
gnomAD
CA7895217
rs761125187
COSM286411
643 D>N lung Variant assessed as Somatic; 0.0 impact. large_intestine [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA7895216
rs753071325
644 G>S No ClinGen
ExAC
gnomAD
CA7895215
rs370128581
645 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs759156719
CA7895214
647 T>R No ClinGen
ExAC
TOPMed
gnomAD
CA394700001
rs1220345080
648 M>I No ClinGen
TOPMed
rs762458977
CA7895191
648 M>V No ClinGen
ExAC
gnomAD
CA394699996
rs1364889961
649 I>L No ClinGen
gnomAD
CA394699992
rs113373249
649 I>M No ClinGen
TOPMed
gnomAD
rs1268381437
CA394699994
649 I>T No ClinGen
TOPMed
CA394699981
rs1470748385
651 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs775237317
CA277506725
652 S>N No ClinGen
ExAC
gnomAD
rs775237317
CA7895189
652 S>T No ClinGen
ExAC
gnomAD
rs1421063569
CA394699937
657 P>S No ClinGen
gnomAD
rs1421063569
CA394699939
657 P>T No ClinGen
gnomAD
CA394699921
rs1453488500
659 T>K No ClinGen
TOPMed
TCGA novel 660 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895187
rs776602318
660 I>V No ClinGen
ExAC
gnomAD
rs200818013
CA277506710
665 V>A No ClinGen
1000Genomes
CA7895186
rs768404148
665 V>I No ClinGen
ExAC
gnomAD
CA7895185
rs746759407
666 D>E No ClinGen
ExAC
gnomAD
rs1310463182
CA394699860
669 L>M No ClinGen
TOPMed
gnomAD
rs1310463182
CA394699859
669 L>V No ClinGen
TOPMed
gnomAD
CA394699846
rs1275260301
671 A>G No ClinGen
gnomAD
CA394699826
rs1478213950
674 A>V No ClinGen
TOPMed
rs112644069
CA277506687
676 L>S No ClinGen
Ensembl
rs1454855657
CA394699773
682 D>N No ClinGen
gnomAD
rs771143610
CA7895183
682 D>V No ClinGen
ExAC
gnomAD
CA394699752
rs1386731940
683 H>R No ClinGen
TOPMed
rs915766757
CA277506663
683 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1296692572
CA394699732
686 M>V No ClinGen
TOPMed
rs780521213
CA7895155
695 K>R No ClinGen
ExAC
gnomAD
rs1348057437
CA394699652
696 T>M No ClinGen
gnomAD
CA277505402
rs930883950
696 T>S No ClinGen
TOPMed
rs548205006
CA7895154
697 R>Q No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 698 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394699630
rs1381019671
700 N>Y No ClinGen
TOPMed
gnomAD
rs750145582
CA7895153
705 I>V No ClinGen
ExAC
gnomAD
CA394699556
rs1223989524
710 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA394699552
rs1291722999
711 C>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs371884501
CA7895151
712 K>I No ClinGen
ESP
ExAC
gnomAD
CA7895150
rs753346185
714 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA394699494
rs1423379442
718 P>A No ClinGen
TOPMed
CA277505233
rs768764601
719 V>L No ClinGen
Ensembl
CA394699477
rs1430846697
720 M>I No ClinGen
gnomAD
rs1188408484
CA394699460
722 D>E No ClinGen
gnomAD
CA394699466
rs1249024986
722 D>H No ClinGen
gnomAD
rs762143956
CA7895124
724 A>G No ClinGen
ExAC
gnomAD
CA7895121
rs760661247
728 Q>E No ClinGen
ExAC
TOPMed
gnomAD
CA394699421
rs1253779507
728 Q>H No ClinGen
gnomAD
CA277505218
rs967952352
729 D>A No ClinGen
TOPMed
CA394699414
rs1454215936
729 D>E No ClinGen
TOPMed
rs967952352
CA394699415
729 D>V No ClinGen
TOPMed
CA394699408
rs1229489754
730 T>S No ClinGen
gnomAD
rs1342854825
CA394699375
735 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1342854825
CA394699374
735 Y>F No ClinGen
gnomAD
rs1377787362
CA394699378
735 Y>H No ClinGen
TOPMed
TCGA novel 737 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 741 N>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs780900283
CA7895093
749 Y>C No ClinGen
ExAC
gnomAD
CA394699247
rs1183913112
751 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA7895091
rs747014527
752 S>C No ClinGen
ExAC
gnomAD
rs1202896462
CA394699226
754 D>G No ClinGen
gnomAD
TCGA novel 758 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895087
rs764397590
762 D>V No ClinGen
ExAC
CA277504777
rs61736975
764 D>A No ClinGen
Ensembl
TCGA novel 764 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7895085
rs752882692
767 V>L No ClinGen
ExAC
gnomAD
rs1056013336 769 Q>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1415639181
CA394699082
772 D>E No ClinGen
gnomAD
CA277503812
rs867579274
773 P>L No ClinGen
gnomAD
CA394699077
rs867579274
773 P>R No ClinGen
gnomAD
CA7895059
rs776441351
776 D>G No ClinGen
ExAC
gnomAD
CA7895057
rs760295224
782 T>A No ClinGen
ExAC
gnomAD
rs1335592230
CA394699007
783 A>V No ClinGen
TOPMed
rs1233500824
CA394698998
784 K>N No ClinGen
TOPMed
rs1289464601
CA394698970
788 R>Q No ClinGen
gnomAD
rs778892813
CA7895053
789 D>A No ClinGen
ExAC
gnomAD
rs745855649
CA7895054
789 D>H No ClinGen
ExAC
gnomAD
CA394698951
rs1279468582
791 Y>C No ClinGen
gnomAD
rs1219132622
CA394698945
792 H>Y No ClinGen
gnomAD
CA394698936
rs1343557524
793 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 795 D>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394698915
rs1364958541
796 V>A No ClinGen
gnomAD
CA394698912
rs1449830124
797 I>V No ClinGen
gnomAD
CA7895048
rs751785158
798 F>L No ClinGen
ExAC
gnomAD
rs780040314
CA7895047
800 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA7895046
rs758501837
802 T>I No ClinGen
ExAC
gnomAD
rs1391865790
CA394698863
804 P>A No ClinGen
gnomAD
CA394698859
rs1179987032
804 P>L No ClinGen
TOPMed
TCGA novel 806 D>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA277503738
rs1024523798
807 P>A No ClinGen
TOPMed
gnomAD
rs750953463
CA7895045
809 F>V No ClinGen
ExAC
gnomAD
CA394698816
rs1229177344
811 V>I No ClinGen
gnomAD
CA394698806
rs1433627689
812 T>M No ClinGen
TOPMed
CA394698791
rs1484386651
815 N>H No ClinGen
gnomAD
rs1173046298
CA394698781
816 R>G No ClinGen
TOPMed
CA394698746
rs1319085921
820 F>C No ClinGen
Ensembl
CA7895013
rs773131309
825 T>S No ClinGen
ExAC
gnomAD
rs1295221475
CA394698677
828 Q>H No ClinGen
gnomAD
CA7895007
rs779171215
831 N>D No ClinGen
ExAC
gnomAD
rs886327757
CA277503338
834 P>A No ClinGen
Ensembl
rs757406176
CA7895006
835 M>V No ClinGen
ExAC
gnomAD
rs753064549
CA7895002
841 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA394698330
rs1169032466
850 G>D No ClinGen
TOPMed
rs1451663216
CA394698304
854 R>K No ClinGen
gnomAD
CA394698299
rs1567207327
855 H>D No ClinGen
Ensembl
rs771237858
CA7894965
873 P>S No ClinGen
ExAC
gnomAD
TCGA novel 875 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764062309
CA277502719
882 K>R No ClinGen
Ensembl
CA7894935
rs772398924
887 D>E No ClinGen
ExAC
gnomAD
rs1415001823
CA394697510
897 I>M No ClinGen
gnomAD
rs1567207144
CA394697520
897 I>V No ClinGen
Ensembl
rs77864036
CA277502714
899 L>* No ClinGen
Ensembl
rs79518720
CA277502711
900 N>T No ClinGen
gnomAD
rs778367249
CA7894934
902 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs140337763
CA7894915
908 I>V No ClinGen
1000Genomes
ExAC
gnomAD
CA394697207
rs567490269
910 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA394697191
rs1283714689
911 Y>H No ClinGen
gnomAD
TCGA novel 911 Y>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777463630
CA7894910
915 H>R No ClinGen
ExAC
gnomAD
rs1290032365
CA394697057
916 G>A No ClinGen
TOPMed
CA7894909
rs755680758
916 G>R No ClinGen
ExAC
gnomAD
rs918769098
CA277501579
919 R>Q No ClinGen
Ensembl
CA394696922
rs1246063116
923 E>Q No ClinGen
TOPMed
CA7894905
rs368894909
929 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs982273663
CA277501576
930 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA7894903
rs757472416
931 L>P No ClinGen
ExAC
CA394696774
rs1476991127
932 G>R No ClinGen
TOPMed
CA7894901
rs557701280
934 K>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1440617810
CA394696756
934 K>T No ClinGen
gnomAD
rs144102588
CA7894899
938 K>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA7894864
rs147523234
947 Y>C No ClinGen
ESP
ExAC
gnomAD
rs752636299
CA277495818
950 I>T No ClinGen
Ensembl
rs1352181861
CA394696408
950 I>V No ClinGen
gnomAD
CA7894862
rs777990074
951 G>A No ClinGen
ExAC
gnomAD
TCGA novel 951 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1407341599
CA394696335
956 D>G No ClinGen
gnomAD
CA394696264
rs1187229581
960 E>K No ClinGen
gnomAD
rs987904914
CA277495799
964 P>A No ClinGen
Ensembl
TCGA novel 965 A>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs765762500
CA277495796
965 A>G No ClinGen
TOPMed
gnomAD
CA394696146
rs1480495786
966 T>M No ClinGen
TOPMed
gnomAD
CA394696109
rs752021202
969 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA7894856
rs766843328
969 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs752021202
CA7894857
969 T>S No ClinGen
ExAC
TOPMed
gnomAD
rs953569164
CA277495748
972 I>T No ClinGen
Ensembl
rs1008163913
CA277495753
972 I>V No ClinGen
TOPMed
gnomAD
TCGA novel 974 E>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394695939
rs1315313550
975 I>T No ClinGen
gnomAD
rs746438324
CA7894819
975 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1435939941
CA394695854
980 V>L No ClinGen
gnomAD
rs1230301328
CA394695819
982 I>V No ClinGen
TOPMed
rs1375207259
CA394695806
983 D>H No ClinGen
gnomAD
TCGA novel 983 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1314682906
CA394695771
985 E>Q No ClinGen
gnomAD
rs1192066042
CA394695697
993 A>V No ClinGen
gnomAD
rs1596346893
CA394695676
996 H>R No ClinGen
Ensembl
rs1188556536
CA394695672
997 K>Q No ClinGen
gnomAD
CA277495295
rs1015166324
997 K>R No ClinGen
TOPMed
CA394695642
rs1206961848
1001 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA7894810
rs774275921
1011 I>L No ClinGen
ExAC
TOPMed
gnomAD
CA277495267
rs774275921
1011 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA394695565
rs1355306601
1012 H>R No ClinGen
TOPMed
gnomAD
rs77998839
CA7894778
1016 H>P No ClinGen
1000Genomes
ExAC
gnomAD
rs77998839
CA7894777
1016 H>R No ClinGen
1000Genomes
ExAC
gnomAD
CA394695506
rs1225974072
1019 E>K No ClinGen
gnomAD
TCGA novel 1021 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA394695479
rs1279506046
1022 K>T No ClinGen
gnomAD
rs751183254
CA7894775
1026 S>G No ClinGen
ExAC
gnomAD
CA7894774
rs142143501
1026 S>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1319795215
CA394695385
1035 F>L No ClinGen
gnomAD
CA7894736
rs745498431
1042 I>V No ClinGen
ExAC
gnomAD
CA7894735
rs778348736
1044 M>V No ClinGen
ExAC
gnomAD
rs756826814
CA7894734
1047 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs749245139
CA7894733
CA394695017
1049 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA394695008
rs1267387155
1051 I>L No ClinGen
TOPMed
rs1483470814
CA394694997
1052 N>S No ClinGen
TOPMed
TCGA novel 1053 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs201268930
CA7894731
1054 D>E No ClinGen
1000Genomes
ExAC
gnomAD
rs371189235
CA7894729
1055 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA394694960
rs1457164287
1057 E>A No ClinGen
gnomAD
rs750643787
CA394694880
1063 F>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 1065 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1441209197
CA394694796
1068 G>S No ClinGen
gnomAD
rs768021471
CA7894658
1069 N>S No ClinGen
ExAC
gnomAD
rs766828801
CA7894655
1070 M>I No ClinGen
ExAC
gnomAD
rs751996046
CA7894656
1070 M>T No ClinGen
ExAC
gnomAD
rs1234755957
COSM130129
CA394694692
1070 M>V upper_aerodigestive_tract [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1416045663
CA394694629
1073 P>S No ClinGen
TOPMed
rs762752076
CA7894654
1074 R>W No ClinGen
ExAC
gnomAD
CA7894650
rs776453439
1080 D>H No ClinGen
ExAC
CA394694447
rs1437674389
1082 F>L No ClinGen
TOPMed
CA394694440
rs1175842044
1083 N>H No ClinGen
gnomAD
rs1021857066
CA277494368
1085 A>V No ClinGen
TOPMed
CA394694347
rs1325421022
1089 S>N No ClinGen
TOPMed
CA394694327
rs1245063609
1090 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA394694323
rs1183781674
1090 R>L No ClinGen
gnomAD
rs1285507074
CA394694250
1096 K>E No ClinGen
TOPMed
CA394694168
rs1229110038
1101 H>R No ClinGen
Ensembl

1 associated diseases with Q93009

[MIM: 616863]: Hao-Fountain syndrome (HAFOUS)

An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, varying degrees of intellectual disability, autism spectrum disorder, poor or absent speech, and mild facial dysmorphism. Most patients develop seizures. Additional variable features include hypotonia, hypogonadism in males, and ocular anomalies. {ECO:0000269|PubMed:26365382, ECO:0000269|PubMed:30679821}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, varying degrees of intellectual disability, autism spectrum disorder, poor or absent speech, and mild facial dysmorphism. Most patients develop seizures. Additional variable features include hypotonia, hypogonadism in males, and ocular anomalies. {ECO:0000269|PubMed:26365382, ECO:0000269|PubMed:30679821}. Note=The disease is caused by variants affecting the gene represented in this entry.

7 regional properties for Q93009

Type Name Position InterPro Accession
domain Peptidase C19, ubiquitin carboxyl-terminal hydrolase 214 - 518 IPR001394
domain MATH/TRAF domain 68 - 195 IPR002083
conserved_site Ubiquitin specific protease, conserved site 215 - 230 IPR018200-1
conserved_site Ubiquitin specific protease, conserved site 448 - 465 IPR018200-2
domain Ubiquitin carboxyl-terminal hydrolase 7, ICP0-binding domain 620 - 865 IPR024729
domain Ubiquitin specific protease domain 214 - 521 IPR028889
domain Ubiquitin carboxyl-terminal hydrolase, C-terminal 875 - 1086 IPR029346

Functions

Description
EC Number 3.4.19.12 Omega peptidases
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Nucleus, PML body
  • Chromosome
  • Present in a minority of ND10 nuclear bodies
  • Association with ICP0/VMW110 at early times of infection leads to an increased proportion of USP7-containing ND10
  • Colocalizes with ATXN1 in the nucleus
  • Colocalized with DAXX in speckled structures
  • Colocalized with PML and PTEN in promyelocytic leukemia protein (PML) nuclear bodies
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
chromosome A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nuclear body Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
PML body A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.

7 GO annotations of molecular function

Name Definition
cysteine-type deubiquitinase activity An thiol-dependent isopeptidase activity that cleaves ubiquitin from a target protein to which it is conjugated.
cysteine-type endopeptidase activity Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.
deubiquitinase activity An isopeptidase activity that cleaves ubiquitin from a target protein to which it is conjugated.
Lys48-specific deubiquitinase activity Hydrolysis of Lys48-linked ubiquitin unit(s) from a ubiquitinated protein.
p53 binding Binding to one of the p53 family of proteins.
protein C-terminus binding Binding to a protein C-terminus, the end of a peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.

20 GO annotations of biological process

Name Definition
histone H2B conserved C-terminal lysine deubiquitination A histone deubiquitination process in which a ubiquitin monomer is removed from a conserved lysine residue in the C-terminus of histone H2B. The conserved lysine residue is K119 in fission yeast, K123 in budding yeast, or K120 in mammals.
maintenance of DNA methylation Any process involved in maintaining the methylation state of a nucleotide sequence.
monoubiquitinated protein deubiquitination The removal of the ubiquitin group from a monoubiquitinated protein.
negative regulation of NF-kappaB transcription factor activity Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB.
negative regulation of proteasomal ubiquitin-dependent protein catabolic process Any process that stops, prevents, or reduces the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
positive regulation of DNA demethylation Any process that activates or increases the frequency, rate or extent of DNA demethylation.
protein deubiquitination The removal of one or more ubiquitin groups from a protein.
protein K63-linked deubiquitination A protein deubiquitination process in which a K63-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is removed from a protein.
protein stabilization Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
protein ubiquitination The process in which one or more ubiquitin groups are added to a protein.
regulation of circadian rhythm Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours.
regulation of DNA-binding transcription factor activity Any process that modulates the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
regulation of gluconeogenesis Any process that modulates the frequency, rate or extent of gluconeogenesis, the formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol.
regulation of protein stability Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation.
regulation of retrograde transport, endosome to Golgi Any process that modulates the frequency, rate or extent of retrograde transport, endosome to Golgi.
regulation of signal transduction by p53 class mediator Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator.
regulation of telomere capping Any process that modulates the frequency, rate or extent of telomere capping.
rhythmic process Any process pertinent to the generation and maintenance of rhythms in the physiology of an organism.
transcription-coupled nucleotide-excision repair The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway.
ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P50101 UBP15 Ubiquitin carboxyl-terminal hydrolase 15 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q9UHP3 USP25 Ubiquitin carboxyl-terminal hydrolase 25 Homo sapiens (Human) EV
Q96K76 USP47 Ubiquitin carboxyl-terminal hydrolase 47 Homo sapiens (Human) PR
Q92995 USP13 Ubiquitin carboxyl-terminal hydrolase 13 Homo sapiens (Human) PR
P45974 USP5 Ubiquitin carboxyl-terminal hydrolase 5 Homo sapiens (Human) PR
P57080 Usp25 Ubiquitin carboxyl-terminal hydrolase 25 Mus musculus (Mouse) SS
Q6A4J8 Usp7 Ubiquitin carboxyl-terminal hydrolase 7 Mus musculus (Mouse) PR
10 20 30 40 50 60
MNHQQQQQQQ KAGEQQLSEP EDMEMEAGDT DDPPRITQNP VINGNVALSD GHNTAEEDME
70 80 90 100 110 120
DDTSWRSEAT FQFTVERFSR LSESVLSPPC FVRNLPWKIM VMPRFYPDRP HQKSVGFFLQ
130 140 150 160 170 180
CNAESDSTSW SCHAQAVLKI INYRDDEKSF SRRISHLFFH KENDWGFSNF MAWSEVTDPE
190 200 210 220 230 240
KGFIDDDKVT FEVFVQADAP HGVAWDSKKH TGYVGLKNQG ATCYMNSLLQ TLFFTNQLRK
250 260 270 280 290 300
AVYMMPTEGD DSSKSVPLAL QRVFYELQHS DKPVGTKKLT KSFGWETLDS FMQHDVQELC
310 320 330 340 350 360
RVLLDNVENK MKGTCVEGTI PKLFRGKMVS YIQCKEVDYR SDRREDYYDI QLSIKGKKNI
370 380 390 400 410 420
FESFVDYVAV EQLDGDNKYD AGEHGLQEAE KGVKFLTLPP VLHLQLMRFM YDPQTDQNIK
430 440 450 460 470 480
INDRFEFPEQ LPLDEFLQKT DPKDPANYIL HAVLVHSGDN HGGHYVVYLN PKGDGKWCKF
490 500 510 520 530 540
DDDVVSRCTK EEAIEHNYGG HDDDLSVRHC TNAYMLVYIR ESKLSEVLQA VTDHDIPQQL
550 560 570 580 590 600
VERLQEEKRI EAQKRKERQE AHLYMQVQIV AEDQFCGHQG NDMYDEEKVK YTVFKVLKNS
610 620 630 640 650 660
SLAEFVQSLS QTMGFPQDQI RLWPMQARSN GTKRPAMLDN EADGNKTMIE LSDNENPWTI
670 680 690 700 710 720
FLETVDPELA ASGATLPKFD KDHDVMLFLK MYDPKTRSLN YCGHIYTPIS CKIRDLLPVM
730 740 750 760 770 780
CDRAGFIQDT SLILYEEVKP NLTERIQDYD VSLDKALDEL MDGDIIVFQK DDPENDNSEL
790 800 810 820 830 840
PTAKEYFRDL YHRVDVIFCD KTIPNDPGFV VTLSNRMNYF QVAKTVAQRL NTDPMLLQFF
850 860 870 880 890 900
KSQGYRDGPG NPLRHNYEGT LRDLLQFFKP RQPKKLYYQQ LKMKITDFEN RRSFKCIWLN
910 920 930 940 950 960
SQFREEEITL YPDKHGCVRD LLEECKKAVE LGEKASGKLR LLEIVSYKII GVHQEDELLE
970 980 990 1000 1010 1020
CLSPATSRTF RIEEIPLDQV DIDKENEMLV TVAHFHKEVF GTFGIPFLLR IHQGEHFREV
1030 1040 1050 1060 1070 1080
MKRIQSLLDI QEKEFEKFKF AIVMMGRHQY INEDEYEVNL KDFEPQPGNM SHPRPWLGLD
1090 1100
HFNKAPKRSR YTYLEKAIKI HN